Pharma BD Deal Intelligence
A $740M bet on neuromodulation/cochlear implants that ended in litigation, a $352M writedown, and a forced unwind — Boston Scientific kept only the spinal-cord-stimulation sliver, while the auditory business it paid for ended up at Sonova.
Full analysis, sources & comparables →Boston Scientific acquired Advanced Bionics for ~$740M cash plus earn-outs tied to performance milestones; the acquired franchise included implantable…
Boston Scientific moved to end its 'rocky' Advanced Bionics relationship, paying $1.15B over two years to former shareholders, retaining pain management, and…
A Swiss company moved to buy the former Boston Scientific unit Advanced Bionics, recapping how the cochlear-implant business ultimately separated from Boston…
Source summaries from our enrichment pipeline; follow links for originals.
All 6 sources with sentiment breakdown →
$740M cash + earnouts; neuromodulation/cochlear/drug pumps; deal later partially unwound 2008
A $740M bet on neuromodulation/cochlear implants that ended in litigation, a $352M writedown, and a forced unwind — Boston Scientific kept only the spinal-cord-stimulation sliver, while the auditory business it paid for ended up at Sonova.
Assessment window: 15yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Boston Scientific Corporation / Advanced Bionics Corporation (this deal) | 2004 | $740M | 26 |
| Boston Scientific Corporation / Endo International plc (American Medical Systems Men's Health and Prostate Health) | 2015 | $1.6B | 82 |
| Boston Scientific Corporation / BTG plc | 2018 | $4.2B | 78 |
| Boston Scientific Corporation / Vertiflex, Inc. | 2019 | $465M | — |
| UCB SA / Celltech Group plc | 2004 | $2.7B | 92 |
| Yamanouchi Pharmaceutical / Fujisawa Pharmaceutical Co. Ltd. | 2004 | $7.6B | 84 |
| Abbott Laboratories / TheraSense Inc. | 2004 | $1.2B | 81 |